Themis Medicare Limited (THEMISMED) - Total Assets

Latest as of September 2025: Rs5.82 Billion INR ≈ $62.99 Million USD

Based on the latest financial reports, Themis Medicare Limited (THEMISMED) holds total assets worth Rs5.82 Billion INR (≈ $62.99 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See THEMISMED book value for net asset value and shareholders' equity analysis.

Themis Medicare Limited - Total Assets Trend (2006–2025)

This chart illustrates how Themis Medicare Limited's total assets have evolved over time, based on quarterly financial data.

Themis Medicare Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Themis Medicare Limited's total assets of Rs5.82 Billion consist of 51.7% current assets and 48.3% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs62.77 Million 1.1%
Accounts Receivable Rs1.77 Billion 30.1%
Inventory Rs843.14 Million 14.3%
Property, Plant & Equipment Rs1.75 Billion 29.7%
Intangible Assets Rs3.34 Million 0.1%
Goodwill Rs0.00 0.0%

Asset Composition Trend (2006–2025)

This chart illustrates how Themis Medicare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see THEMISMED market cap overview.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Themis Medicare Limited's current assets represent 51.7% of total assets in 2025, a decrease from 55.4% in 2006.
  • Cash Position: Cash and equivalents constituted 1.1% of total assets in 2025, down from 1.7% in 2006.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2006.
  • Asset Diversification: The largest asset category is accounts receivable at 30.1% of total assets.

Themis Medicare Limited Competitors by Total Assets

Key competitors of Themis Medicare Limited based on total assets are shown below.

Company Country Total Assets
Changchun High & New Technology Industries Group Inc
SHE:000661
China CN¥31.46 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Tasly Pharmaceutical Group Co Ltd
SHG:600535
China CN¥15.34 Billion
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
China CN¥15.32 Billion
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
China CN¥10.96 Billion
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
China CN¥1.54 Billion
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
China CN¥6.74 Billion
Cronos Group Inc
TO:CRON
Canada CA$1.18 Billion

Themis Medicare Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.72 1.97 1.31
Quick Ratio 1.28 1.56 0.90
Cash Ratio 0.03 0.05 0.00
Working Capital Rs1.25 Billion Rs1.54 Billion Rs428.26 Million

Themis Medicare Limited - Advanced Valuation Insights

This section examines the relationship between Themis Medicare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.19
Latest Market Cap to Assets Ratio 0.02
Asset Growth Rate (YoY) 3.8%
Total Assets Rs5.88 Billion
Market Capitalization $98.31 Million USD

Valuation Analysis

Below Book Valuation: The market values Themis Medicare Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Themis Medicare Limited's assets grew by 3.8% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Themis Medicare Limited (2006–2025)

The table below shows the annual total assets of Themis Medicare Limited from 2006 to 2025.

Year Total Assets Change
2025-03-31 Rs5.88 Billion
≈ $63.59 Million
+3.82%
2024-03-31 Rs5.66 Billion
≈ $61.26 Million
+10.21%
2023-03-31 Rs5.14 Billion
≈ $55.58 Million
+20.14%
2022-03-31 Rs4.28 Billion
≈ $46.26 Million
+15.26%
2021-03-31 Rs3.71 Billion
≈ $40.14 Million
+6.07%
2020-03-31 Rs3.50 Billion
≈ $37.84 Million
+11.40%
2019-03-31 Rs3.14 Billion
≈ $33.97 Million
+2.90%
2018-03-31 Rs3.05 Billion
≈ $33.01 Million
-1.45%
2017-03-31 Rs3.10 Billion
≈ $33.50 Million
+12.18%
2016-03-31 Rs2.76 Billion
≈ $29.86 Million
-1.13%
2015-03-31 Rs2.79 Billion
≈ $30.21 Million
-1.97%
2014-03-31 Rs2.85 Billion
≈ $30.81 Million
+4.21%
2013-03-31 Rs2.73 Billion
≈ $29.57 Million
-2.21%
2012-03-31 Rs2.80 Billion
≈ $30.24 Million
-4.90%
2011-03-31 Rs2.94 Billion
≈ $31.79 Million
+6.49%
2010-03-31 Rs2.76 Billion
≈ $29.86 Million
-6.22%
2009-03-31 Rs2.94 Billion
≈ $31.84 Million
+7.93%
2008-03-31 Rs2.73 Billion
≈ $29.50 Million
+17.87%
2007-03-31 Rs2.31 Billion
≈ $25.02 Million
+47.01%
2006-03-31 Rs1.57 Billion
≈ $17.02 Million
--

About Themis Medicare Limited

NSE:THEMISMED India Drug Manufacturers - Specialty & Generic
Market Cap
$98.31 Million
Rs9.09 Billion INR
Market Cap Rank
#19249 Global
#1028 in India
Share Price
Rs98.70
Change (1 day)
+5.26%
52-Week Range
Rs66.07 - Rs170.74
All Time High
Rs300.15
About

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic,… Read more